Enno C. I. Veerman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Enno C. I. Veerman has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
A V Nieuw Amerongen
4 shared publicationsA. V. Nieuw Amerongen
3 shared publicationsArie V. Nieuw Amerongen
2 shared publications- H S Brand
Department of Dental Basic Sciences, Section of Oral Biochemistry, Academic Centre for Dentistry Amsterdam, Vrije Universiteit, The Netherlands
2 shared publications - M F Blankenvoorde
Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam (ACTA), The Netherlands
2 shared publications W Van'T Hof
2 shared publications
Latest Publications
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S603
EP-1573 MUC5B CONTENT OF SUBMANDIBULAR SALIVA IN PATIENTS TREATED WITH RADIOTHERAPY FOR HEAD-AND-NECK CANCER: PILOT STUDY
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S603
EP-1573 MUC5B CONTENT OF SUBMANDIBULAR SALIVA IN PATIENTS TREATED WITH RADIOTHERAPY FOR HEAD-AND-NECK CANCER: PILOT STUDY
- 1 December 2004
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 385 (12) , 1137-1146
Neuroendocrine regulation of salivary IgA synthesis and secretion: implications for oral health
Secretory immunoglobulin A (S-IgA) represents the main adaptive immune mechanism in the oral cavity. The regulation of secretion and synthesis of S-IgA is not only dependent on prior antigenic stimulation, but is also under strong neuroendocrine control. Thus, alterations in neuroendocrine functioning (such as induced by stress, exercise, pregnancy, menstrual cycle, and pharmacological interventions) may affect salivary IgA levels. This review deals with the neuroendocrine regulation of synthesis and secretion of salivary IgA and its potential role in the maintenance of oral health.
- 1 December 2004
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 385 (12) , 1137-1146
Neuroendocrine regulation of salivary IgA synthesis and secretion: implications for oral health
Secretory immunoglobulin A (S-IgA) represents the main adaptive immune mechanism in the oral cavity. The regulation of secretion and synthesis of S-IgA is not only dependent on prior antigenic stimulation, but is also under strong neuroendocrine control. Thus, alterations in neuroendocrine functioning (such as induced by stress, exercise, pregnancy, menstrual cycle, and pharmacological interventions) may affect salivary IgA levels. This review deals with the neuroendocrine regulation of synthesis and secretion of salivary IgA and its potential role in the maintenance of oral health.
- 6 July 2004
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 381 (2) , 447-452
Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5
The mechanism of action of antimicrobial peptides is still a matter of debate. The formation of ROS (reactive oxygen species) has been suggested to be the crucial step in the fungicidal mechanism of a number of antimicrobial peptides, including histatin 5 and lactoferrin-derived peptides. In the present study we have investigated the effects of histatin 5 and of a more amphipathic synthetic derivative, dhvar4, on the generation of ROS in the yeast Candida albicans, using dihydroethidium as an indicator for ROS. With both peptides, a substantial enhancement of fluorescence was observed. However, TEMPO (2,2,6,6-tetramethylpiperidine-N-oxyl), a cell-permeant ROS scavenger, did not have an inhibitory effect on killing or on the enhancement of fluorescence. Furthermore, antimycin and azide, which have been reported to induce ROS in vitro, were not able to enhance the dihydroethidium fluorescence, while chlorhexidine, a non-specific antiseptic agent, enhanced dihydroethidium fluorescence to the same extent as did the peptides. Fluorescence microscopy showed the fluorescence enhancement to be a consequence of the release of unbound preformed ethidium from the mitochondrial matrix within the cell. It is concluded that ROS do not play a role in the histatin 5-mediated killing of C. albicans.
- 6 July 2004
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 381 (2) , 447-452
Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5
The mechanism of action of antimicrobial peptides is still a matter of debate. The formation of ROS (reactive oxygen species) has been suggested to be the crucial step in the fungicidal mechanism of a number of antimicrobial peptides, including histatin 5 and lactoferrin-derived peptides. In the present study we have investigated the effects of histatin 5 and of a more amphipathic synthetic derivative, dhvar4, on the generation of ROS in the yeast Candida albicans, using dihydroethidium as an indicator for ROS. With both peptides, a substantial enhancement of fluorescence was observed. However, TEMPO (2,2,6,6-tetramethylpiperidine-N-oxyl), a cell-permeant ROS scavenger, did not have an inhibitory effect on killing or on the enhancement of fluorescence. Furthermore, antimycin and azide, which have been reported to induce ROS in vitro, were not able to enhance the dihydroethidium fluorescence, while chlorhexidine, a non-specific antiseptic agent, enhanced dihydroethidium fluorescence to the same extent as did the peptides. Fluorescence microscopy showed the fluorescence enhancement to be a consequence of the release of unbound preformed ethidium from the mitochondrial matrix within the cell. It is concluded that ROS do not play a role in the histatin 5-mediated killing of C. albicans.
- Open Access
- 3 January 2003
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 13 (5) , 363-366
Distinct localization of MUC5B glycoforms in the human salivary glands
Salivary mucins, encoded by the MUC5B gene, make up a heterogeneous family of molecules, which are secreted by several glands, including the submandibular, sublingual, and palatine glands. Previous studies have shown that heterogeneity in the salivary mucin population is related to its multiglandular origin. In the present study we address the question to what extent the mucin (MUC5B) population from a single human salivary gland is made up of different glycoforms. Using monoclonal antibodies to defined protein and sulfated carbohydrate epitopes specific to MUC5B, we conduct an immunohistochemical study of different salivary gland types, including submandibular, sublingual, and labial glands. In all tissues studied we found a mosaic expression pattern of sulfo-Lewis a antigen, recognized by mAb F2, which in salivary glands is exclusively present on MUC5B. On the other hand, mucous acini were uniformly labeled by mAb EU-MUC5Bb, evoked against a peptide-stretch of the tandem repeat region of MUC5B. Double staining with both antibodies confirmed the presence of MUC5B-positive/sulfo-Lewis a‐positive cells, as well as MUC5B-positive/sulfo-Lewis a‐negative cells within one glandular unit. These results indicate that one and the same salivary gland synthesizes different MUC5B glycoforms.
- 3 January 2003
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 13 (5) , 363-366
Open AccessDistinct localization of MUC5B glycoforms in the human salivary glands
Salivary mucins, encoded by the MUC5B gene, make up a heterogeneous family of molecules, which are secreted by several glands, including the submandibular, sublingual, and palatine glands. Previous studies have shown that heterogeneity in the salivary mucin population is related to its multiglandular origin. In the present study we address the question to what extent the mucin (MUC5B) population from a single human salivary gland is made up of different glycoforms. Using monoclonal antibodies to defined protein and sulfated carbohydrate epitopes specific to MUC5B, we conduct an immunohistochemical study of different salivary gland types, including submandibular, sublingual, and labial glands. In all tissues studied we found a mosaic expression pattern of sulfo-Lewis a antigen, recognized by mAb F2, which in salivary glands is exclusively present on MUC5B. On the other hand, mucous acini were uniformly labeled by mAb EU-MUC5Bb, evoked against a peptide-stretch of the tandem repeat region of MUC5B. Double staining with both antibodies confirmed the presence of MUC5B-positive/sulfo-Lewis a‐positive cells, as well as MUC5B-positive/sulfo-Lewis a‐negative cells within one glandular unit. These results indicate that one and the same salivary gland synthesizes different MUC5B glycoforms.
- 11 September 2002
- Published by Elsevier in Archives of Oral Biology
- Vol. 47 (11) , 749-756
Effects of carbohydrate polymers applicable in saliva substitutes on the anti-Candida activity of a histatin-derived peptide
- 11 September 2002
- Published by Elsevier in Archives of Oral Biology
- Vol. 47 (11) , 749-756
Effects of carbohydrate polymers applicable in saliva substitutes on the anti-Candida activity of a histatin-derived peptide
- 1 November 1998
- Vol. 379 (11) , 1371-5
Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis.
We investigated whether cystatins and cystatin-derived peptides, encompassing sequences of secondary structures of cystatin S and papain binding domains of cystatin C, display antimicrobial properties. Of the different microorganisms tested, only the growth of P. gingivalis was inhibited by chicken cystatin and cystatin C. Cystatin S, cystatin S:1-14, cystatin S:61-73 and cystatin S:108-121 also inhibited its growth, whereas cystatin S:21-38, cystatin S:39-55, cystatin S:81-95, cystatin S:94-109, and cystatin C: 9-12/55-60/106-107 did not. No inhibition of the cysteine proteinase activity of P. gingivalis was observed for all cystatin-derived peptides. On the other hand, leupeptin and antipain inhibited P. gingivalis proteinase activity, but had no effect on the growth. These data suggest that cystatins contain antibacterial sequences active against P. gingivalis and that the growth inhibition does not depend on the inhibition of P. gingivalis cysteine proteinases.
- 1 November 1998
- Vol. 379 (11) , 1371-5
Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis.
We investigated whether cystatins and cystatin-derived peptides, encompassing sequences of secondary structures of cystatin S and papain binding domains of cystatin C, display antimicrobial properties. Of the different microorganisms tested, only the growth of P. gingivalis was inhibited by chicken cystatin and cystatin C. Cystatin S, cystatin S:1-14, cystatin S:61-73 and cystatin S:108-121 also inhibited its growth, whereas cystatin S:21-38, cystatin S:39-55, cystatin S:81-95, cystatin S:94-109, and cystatin C: 9-12/55-60/106-107 did not. No inhibition of the cysteine proteinase activity of P. gingivalis was observed for all cystatin-derived peptides. On the other hand, leupeptin and antipain inhibited P. gingivalis proteinase activity, but had no effect on the growth. These data suggest that cystatins contain antibacterial sequences active against P. gingivalis and that the growth inhibition does not depend on the inhibition of P. gingivalis cysteine proteinases.
- 1 December 1996
- Vol. 377 (12) , 847-50
Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin.
The mutual effects of P. gingivalis and several cystatin species has been investigated. After incubation with P. gingivalis culture supernatant, cystatin S, cystatin C and chicken cystatin were truncated from a 14 kDa protein into a polypeptide of approximately 13 kDa. Amino acid sequence analysis of the truncated cystatin S polypeptide revealed that cystatin S was cleaved after Arg-8. All three types of truncated cystatins fully retained their inhibitory activity toward papain. Cystatin S and chicken cystatin partially inhibited proteolytic activity in the culture supernatant of P. gingivalis. Furthermore, cystatin S and chicken cystatin inhibited the growth of P. gingivalis in culture to 50% at approximately 1 microM.
- 1 December 1996
- Vol. 377 (12) , 847-50
Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin.
The mutual effects of P. gingivalis and several cystatin species has been investigated. After incubation with P. gingivalis culture supernatant, cystatin S, cystatin C and chicken cystatin were truncated from a 14 kDa protein into a polypeptide of approximately 13 kDa. Amino acid sequence analysis of the truncated cystatin S polypeptide revealed that cystatin S was cleaved after Arg-8. All three types of truncated cystatins fully retained their inhibitory activity toward papain. Cystatin S and chicken cystatin partially inhibited proteolytic activity in the culture supernatant of P. gingivalis. Furthermore, cystatin S and chicken cystatin inhibited the growth of P. gingivalis in culture to 50% at approximately 1 microM.
- 1 August 1996
- Published by Wiley in European Journal of Oral Sciences
- Vol. 104 (4) , 346-352
Human glandular salivas: their separate collection and analysis
Human saliva is secreted by the three pairs of major salivary glands (parotid, submandibular, and sublingual), and numerous minor ones, e.g. labial, buccal and (glosso)palatine glands. Using individually adapted collection devices, sublingual. submandibular, parotid and palatine secretions of five individuals were collected and analyzed. Electrophoretic analysis revealed that each type of saliva possesses characteristic features, despite interindividual variations. Parotid salivas are characterized by intensely staining amylase and proline‐rich protein bands, but contain minute amounts of cystatins. lysozyme and the extra‐parotid glycoprotein. Sublingual salivas are characterized by high concentrations of both types of salivary mucins. MG1 and MG2, and contain relatively high levels of lysozyme. Submandibular salivas contain highest concentration of salivary cystatin S. Palatine secretions contain high molecular weight mucins and a relatively high amylase concentration.
- 1 August 1996
- Published by Wiley in European Journal of Oral Sciences
- Vol. 104 (4) , 346-352
Human glandular salivas: their separate collection and analysis
Human saliva is secreted by the three pairs of major salivary glands (parotid, submandibular, and sublingual), and numerous minor ones, e.g. labial, buccal and (glosso)palatine glands. Using individually adapted collection devices, sublingual. submandibular, parotid and palatine secretions of five individuals were collected and analyzed. Electrophoretic analysis revealed that each type of saliva possesses characteristic features, despite interindividual variations. Parotid salivas are characterized by intensely staining amylase and proline‐rich protein bands, but contain minute amounts of cystatins. lysozyme and the extra‐parotid glycoprotein. Sublingual salivas are characterized by high concentrations of both types of salivary mucins. MG1 and MG2, and contain relatively high levels of lysozyme. Submandibular salivas contain highest concentration of salivary cystatin S. Palatine secretions contain high molecular weight mucins and a relatively high amylase concentration.
- Open Access
- 1 January 1995
- Published by Taylor & Francis in Microbial Ecology in Health and Disease
- Vol. 8 (5) , 243-254
Attachment ofStreptococcus gordoniiHG 222 toStreptococcus oralisNy 586 and the Influence of Saliva
The binding of Streptococcus gordonii HG 222 to other streptococci was tested by coaggregation and by binding to immobilised bacteria in an ELISA assay. Out of 17 streptococcal strains, HG 222 coaggregated only with Streptococcus sanguis HG 1470 and Streptococcus oralis Ny 586. Binding of HG 222 to immobilised bacteria also occurred only with HG 1470 and NY 586. Binding of HG 222 to S. oralis Ny 586 was further investigated. Preincubation of Ny 586 coated microtitreplates with whole saliva, parotid, submandibular and sublingual saliva enhanced binding of HG 222 to Ny 586. Several salivary substances bound to both HG 222 and Ny 586, namely low molecular weight mucins, salivary agglutinin, and IgA. There were indications that binding of HG 222 to Ny 586 was especially enhanced by IgA. Binding of IgA to both bacteria could be demonstrated with all the types of glandular saliva. In addition, purified colostral IgA enhanced binding of HG 222 to Ny 586. Saliva preincubation of Ny 586 coated microtitreplates in the presence of antiserum against the IgA a-chain inhibited saliva mediated binding of HG 222 to Ny 586. In this case, binding of salivary agglutinin to Ny 586 was also inhibited, suggesting complexation between IgA and agglutinin. In conclusion, these results indicate that colonisation of dental surfaces by S. gordonii may be accomplished by binding to strains of S. oralis or 5. sanguis. This process may be enhanced by IgA in saliva.
- 1 January 1995
- Published by Taylor & Francis in Microbial Ecology in Health and Disease
- Vol. 8 (5) , 243-254
Open AccessAttachment ofStreptococcus gordoniiHG 222 toStreptococcus oralisNy 586 and the Influence of Saliva
The binding of Streptococcus gordonii HG 222 to other streptococci was tested by coaggregation and by binding to immobilised bacteria in an ELISA assay. Out of 17 streptococcal strains, HG 222 coaggregated only with Streptococcus sanguis HG 1470 and Streptococcus oralis Ny 586. Binding of HG 222 to immobilised bacteria also occurred only with HG 1470 and NY 586. Binding of HG 222 to S. oralis Ny 586 was further investigated. Preincubation of Ny 586 coated microtitreplates with whole saliva, parotid, submandibular and sublingual saliva enhanced binding of HG 222 to Ny 586. Several salivary substances bound to both HG 222 and Ny 586, namely low molecular weight mucins, salivary agglutinin, and IgA. There were indications that binding of HG 222 to Ny 586 was especially enhanced by IgA. Binding of IgA to both bacteria could be demonstrated with all the types of glandular saliva. In addition, purified colostral IgA enhanced binding of HG 222 to Ny 586. Saliva preincubation of Ny 586 coated microtitreplates in the presence of antiserum against the IgA a-chain inhibited saliva mediated binding of HG 222 to Ny 586. In this case, binding of salivary agglutinin to Ny 586 was also inhibited, suggesting complexation between IgA and agglutinin. In conclusion, these results indicate that colonisation of dental surfaces by S. gordonii may be accomplished by binding to strains of S. oralis or 5. sanguis. This process may be enhanced by IgA in saliva.